Susanne B Haga
Professor in Medicine
My research interests focus on issues affecting the translation of genomics to clinical practice. Specifically, I have a strong interest in education, with each of my research projects involving some component of professional, public or patient education, including development of educational materials about genomic research in general, pharmacogenetic testing, and communicating genetic test results, in addition to undergraduate teaching in genetics/genomics, ethics, and policy.
Areas of expertise: Bioethics and Health Behavior
Areas of expertise: Bioethics and Health Behavior
Current Appointments & Affiliations
- Professor in Medicine, Medicine, General Internal Medicine, Medicine 2023
- Associate Research Professor in the Sanford School of Public Policy, Sanford School of Public Policy, Duke University 2014
- Associate Research Professor of Biology, Biology, Trinity College of Arts & Sciences 2018
- Affiliate of the Duke Initiative for Science & Society, Duke Science & Society, Initiatives 2014
- Executive Team Member of Duke Center for Applied Genomics and Precision Medicine, Duke Center for Applied Genomics and Precision Medicine, Medicine 2014
Contact Information
- 101 Science Drive - CIEMAS Bldg, Box 3382, Durham, NC 27708
- 101 Science Drive, Box 3382 CIEMAS Suite 2180, Durham, NC 27708
-
susanne.haga@duke.edu
(919) 684-0325
- Background
-
Education, Training, & Certifications
- Ph.D., University of Maryland, Baltimore 1999
-
Previous Appointments & Affiliations
- Associate Professor in Medicine, Medicine, General Internal Medicine, Medicine 2021 - 2023
- Associate Professor in Medicine, Medicine, General Internal Medicine, Medicine 2014 - 2020
- Associate Research Professor in the Institute for Genome Sciences & Policy, Institutes and Centers, School of Medicine 2012 - 2014
- Assistant Research Professor in the Sanford School of Public Policy, Sanford School of Public Policy, Duke University 2007 - 2012
- Assistant Research Professor in the Institute for Genome Sciences & Policy, Institutes and Centers, School of Medicine 2006 - 2012
- Recognition
-
In the News
-
DEC 28, 2021 Wired Magazine -
SEP 15, 2015 Scientific American
-
- Research
-
Selected Grants
- NHGRI Research Training and Career Development Annual Meeting awarded by National Institutes of Health 2021 - 2023
- Preparing Genetic Counselors for Genomic Medicine Research awarded by National Institutes of Health 2017 - 2023
- Postdoctoral Training in Genomic Medicine Research awarded by National Institutes of Health 2017 - 2023
- IRES Track 1 IRTG Engaged in Dissecting and Reengineering the Regulatory Genome awarded by National Science Foundation 2019 - 2023
- Implementing Pharmacogenomics in Diverse Health Care Systems awarded by National Institutes of Health 2021 - 2022
- Pharmacogenetic Testing: Challenges of Clinical Integration awarded by National Institutes of Health 2011 - 2020
- VGER, The Vanderbilt Genome-Electronic Records Project awarded by Vanderbilt University Medical Center 2018 - 2020
- IPA -Rachel Mills awarded by Durham Veterans Affairs Medical Center 2019
- Impact of Personal Genomic Testing on Primary Care Physician Knowledge and Attitudes awarded by 23andMe, Inc 2017 - 2018
- Genetic Risk Testing & Health Coaching for T2D and CHD awarded by Air Force Office of Scientific Research 2013 - 2017
- Pharmacogenetic Testing: Challenges of Clinical Integration awarded by National Institutes of Health 2007 - 2015
- Implications of Health and Genetic Literacy for Genomic Medicine awarded by National Institutes of Health 2010 - 2012
- CTSA UL awarded by National Institutes of Health 2006 - 2012
- Enabling Personalized Medicine through Clinical Decision Support awarded by National Institutes of Health 2008 - 2011
- Genome Diner: A strategy for community-researcher engagement in genome sciences awarded by National Institutes of Health 2008 - 2010
- Exploring Attitudes About Data Disclosure and Data-Sharing in Genomics Research awarded by National Institutes of Health 2007 - 2009
-
External Relationships
- Institute for Medical Research
- National Institutes of Health (NIH)
- Publications & Artistic Works
-
Selected Publications
-
Books
-
Haga, S. B. The book of genes and genomes, 2022. https://doi.org/10.1007/978-0-387-70916-1.Full Text
-
-
Academic Articles
-
Haga, Susanne B., and Lori A. Orlando. “Expanding Family Health History to Include Family Medication History.” J Pers Med 13, no. 3 (February 25, 2023). https://doi.org/10.3390/jpm13030410.Full Text Link to Item
-
Haga, Susanne B., Wendy K. Chung, Luis A. Cubano, Timothy B. Curry, Philip E. Empey, Geoffrey S. Ginsburg, Kara Mangold, et al. “Development of Competency-based Online Genomic Medicine Training (COGENT).” Per Med 20, no. 1 (January 2023): 55–64. https://doi.org/10.2217/pme-2022-0101.Full Text Link to Item
-
Haga, Susanne B. “Conference Report: NHGRI Research Training and Career Development Annual Meeting.” Per Med, October 18, 2022. https://doi.org/10.2217/pme-2022-0095.Full Text Link to Item
-
Sperber, Nina R., Deborah Cragun, Megan C. Roberts, Lisa M. Bendz, Parker Ince, Sarah Gonzales, Susanne B. Haga, et al. “A Mixed-Methods Protocol to Identify Best Practices for Implementing Pharmacogenetic Testing in Clinical Settings.” J Pers Med 12, no. 8 (August 13, 2022). https://doi.org/10.3390/jpm12081313.Full Text Link to Item
-
Bond, Sarah J., Nathan Parikh, Shrey Majmudar, Sabrina Pin, Christine Wang, Lauren Willis, and Susanne B. Haga. “A Systematic Review of the Scope of Study of mHealth Interventions for Wellness and Related Challenges in Pediatric and Young Adult Populations.” Adolesc Health Med Ther 13 (2022): 23–38. https://doi.org/10.2147/AHMT.S342811.Full Text Link to Item
-
Sharma, Yashoda, Livia Cox, Lucie Kruger, Veena Channamsetty, and Susanne B. Haga. “Evaluating Primary Care Providers' Readiness for Delivering Genetic and Genomic Services to Underserved Populations.” Public Health Genomics, September 7, 2021, 1–10. https://doi.org/10.1159/000518415.Full Text Link to Item
-
Kantor, Ariel, and Susanne B. Haga. “The Potential Benefit of Expedited Development and Approval Programs in Precision Medicine.” J Pers Med 11, no. 1 (January 14, 2021). https://doi.org/10.3390/jpm11010045.Full Text Link to Item
-
Haga, Susanne B. “Revisiting Secondary Information Related to Pharmacogenetic Testing.” Front Genet 12 (2021): 741395. https://doi.org/10.3389/fgene.2021.741395.Full Text Link to Item
-
Haga, Susanne B., Rachel Mills, Jivan Moaddeb, Yiling Liu, and Deepak Voora. “Delivery of Pharmacogenetic Testing with or without Medication Therapy Management in a Community Pharmacy Setting.” Pharmgenomics Pers Med 14 (2021): 785–96. https://doi.org/10.2147/PGPM.S314961.Full Text Link to Item
-
Haga, Susanne B., Rachel Mills, Jivan Moaddeb, Yiling Liu, and Deepak Voora. “Independent Community Pharmacists' Experience in Offering Pharmacogenetic Testing.” Pharmgenomics Pers Med 14 (2021): 877–86. https://doi.org/10.2147/PGPM.S314972.Full Text Link to Item
-
Haga, Susanne B. “Individualizing pharmacogenomic test results in the context of the microbiome.” Per Med 17, no. 6 (November 2020): 459–68. https://doi.org/10.2217/pme-2020-0077.Full Text Link to Item
-
Brown, Lisa, Seenae Eum, Susanne B. Haga, Jeffrey R. Strawn, and Heather Zierhut. “Clinical Utilization of Pharmacogenetics in Psychiatry - Perspectives of Pharmacists, Genetic Counselors, Implementation Science, Clinicians, and Industry.” Pharmacopsychiatry 53, no. 4 (July 2020): 162–73. https://doi.org/10.1055/a-0975-9595.Full Text Link to Item
-
Haga, Susanne B. “Toward digital-based interventions for medication adherence and safety.” Expert Opin Drug Saf 19, no. 6 (June 2020): 735–46. https://doi.org/10.1080/14740338.2020.1764935.Full Text Link to Item
-
Haga, Susanne B., and Lori A. Orlando. “The enduring importance of family health history in the era of genomic medicine and risk assessment.” Per Med 17, no. 3 (May 1, 2020): 229–39. https://doi.org/10.2217/pme-2019-0091.Full Text Open Access Copy Link to Item
-
Haga, Susanne B., Ryan Shaw, Charles Kneifel, Sarah J. Bond, and Geoffrey S. Ginsburg. “Promoting Wellness Through Mobile Health Technology in a College Student Population: Protocol Development and Pilot Study.” Jmir Res Protoc 9, no. 4 (April 3, 2020): e16474. https://doi.org/10.2196/16474.Full Text Link to Item
-
Phillips, K., and S. Haga. “Precision Medicine in Primary Care: Bespoke. Genetic and Genomic. And Maybe Not Ready.” Managed Care 28, no. 12 (December 1, 2019): 30–33.
-
Haga, Susanne B. “Managing Increased Accessibility to Pharmacogenomic Data.” Clinical Pharmacology and Therapeutics 106, no. 5 (November 2019): 922–24. https://doi.org/10.1002/cpt.1602.Full Text
-
Haga, Susanne B., Ryan Shaw, Charles Kneifel, Sarah J. Bond, and Geoffrey S. Ginsburg. “Promoting Wellness Through Mobile Health Technology in a College Student Population: Protocol Development and Pilot Study (Preprint),” October 2, 2019. https://doi.org/10.2196/preprints.16474.Full Text
-
Weitzel, Kristin Wiisanen, Benjamin Q. Duong, Meghan J. Arwood, Aniwaa Owusu-Obeng, Noura S. Abul-Husn, Barbara A. Bernhardt, Brian Decker, et al. “A stepwise approach to implementing pharmacogenetic testing in the primary care setting.” Pharmacogenomics 20, no. 15 (October 2019): 1103–12. https://doi.org/10.2217/pgs-2019-0053.Full Text Link to Item
-
Haga, Susanne B. “First Responder to Genomic Information: A Guide for Primary Care Providers.” Mol Diagn Ther 23, no. 4 (August 2019): 459–66. https://doi.org/10.1007/s40291-019-00407-z.Full Text Link to Item
-
Villegas, Catalina, and Susanne B. Haga. “Access to Genetic Counselors in the Southern United States.” J Pers Med 9, no. 3 (July 1, 2019). https://doi.org/10.3390/jpm9030033.Full Text Link to Item
-
Haga, Susanne B., and Jivan Moaddeb. “Pharmacogenomics courses in pharmacy school curricula.” Pharmacogenomics 20, no. 9 (June 2019): 625–30. https://doi.org/10.2217/pgs-2019-0024.Full Text Link to Item
-
Haga, Susanne B., and Yiling Liu. “Patient characteristics, experiences and perceived value of pharmacogenetic testing from a single testing laboratory.” Pharmacogenomics 20, no. 8 (June 2019): 581–87. https://doi.org/10.2217/pgs-2019-0006.Full Text Link to Item
-
Haga, Susanne B., Esther Kim, Rachel A. Myers, and Geoffrey S. Ginsburg. “Primary Care Physicians' Knowledge, Attitudes, and Experience with Personal Genetic Testing.” J Pers Med 9, no. 2 (May 24, 2019). https://doi.org/10.3390/jpm9020029.Full Text Link to Item
-
Wu, R Ryanne, Rachel A. Myers, Adam H. Buchanan, David Dimmock, Kimberly G. Fulda, Irina V. Haller, Susanne B. Haga, et al. “Effect of Sociodemographic Factors on Uptake of a Patient-Facing Information Technology Family Health History Risk Assessment Platform.” Appl Clin Inform 10, no. 2 (March 2019): 180–88. https://doi.org/10.1055/s-0039-1679926.Full Text Link to Item
-
Haga, Susanne B. “Pharmacogenomic Testing In Pediatrics: Navigating The Ethical, Social, And Legal Challenges.” Pharmgenomics Pers Med 12 (2019): 273–85. https://doi.org/10.2147/PGPM.S179172.Full Text Link to Item
-
Madhavan, Sarina, Emily Bullis, Rachel Myers, Chris J. Zhou, Elise M. Cai, Anu Sharma, Shreya Bhatia, Lori A. Orlando, and Susanne B. Haga. “Awareness of family health history in a predominantly young adult population.” Plos One 14, no. 10 (2019): e0224283. https://doi.org/10.1371/journal.pone.0224283.Full Text Link to Item
-
Peyser, Bruce, Emily P. Perry, Kavisha Singh, Rosalynn D. Gill, Michael R. Mehan, Susanne B. Haga, Michael D. Musty, et al. “Effects of Delivering SLCO1B1 Pharmacogenetic Information in Randomized Trial and Observational Settings.” Circ Genom Precis Med 11, no. 9 (September 2018): e002228. https://doi.org/10.1161/CIRCGEN.118.002228.Full Text Link to Item
-
Haga, Susanne B., and Ariel Kantor. “Horizon Scan Of Clinical Laboratories Offering Pharmacogenetic Testing.” Health Aff (Millwood) 37, no. 5 (May 2018): 717–23. https://doi.org/10.1377/hlthaff.2017.1564.Full Text Link to Item
-
Mills, Rachel, and Susanne B. Haga. “Qualitative user evaluation of a revised pharmacogenetic educational toolkit.” Pharmgenomics Pers Med 11 (2018): 139–46. https://doi.org/10.2147/PGPM.S169648.Full Text Link to Item
-
Haga, Susanne B., Bethany Friedman, and Gabriele Richard. “Considering the Benefits and Risks of Research Participants' Access to Sequence Data.” Genet Test Mol Biomarkers 21, no. 12 (December 2017): 717–21. https://doi.org/10.1089/gtmb.2017.0143.Full Text Link to Item
-
Huddleston, Kathi L., Elisabeth Klein, Alma Fuller, Grace Jo, Grace Lawrence, and Susanne B. Haga. “Introducing personalized health for the family: the experience of a single hospital system.” Pharmacogenomics 18, no. 17 (November 2017): 1589–94. https://doi.org/10.2217/pgs-2017-0112.Full Text Link to Item
-
Haga, Susanne B. “Informational Quest.” Circ Cardiovasc Genet 10, no. 4 (August 2017). https://doi.org/10.1161/CIRCGENETICS.117.001860.Full Text Link to Item
-
Haga, Susanne B. “Educating patients and providers through comprehensive pharmacogenetic test reports.” Pharmacogenomics 18, no. 11 (July 2017): 1047–50. https://doi.org/10.2217/pgs-2017-0088.Full Text Link to Item
-
Mills, Rachel, Megan Ensinger, Nancy Callanan, and Susanne B. Haga. “Development and Initial Assessment of a Patient Education Video about Pharmacogenetics.” J Pers Med 7, no. 2 (May 25, 2017). https://doi.org/10.3390/jpm7020004.Full Text Link to Item
-
Haga, Susanne B. “Update: looking beyond the 100,000 Genome Project.” Per Med 14, no. 2 (March 2017): 85–87. https://doi.org/10.2217/pme-2016-0101.Full Text Link to Item
-
Haga, Susanne B., Jivan Moaddeb, Rachel Mills, and Deepak Voora. “Assessing feasibility of delivering pharmacogenetic testing in a community pharmacy setting.” Pharmacogenomics 18, no. 4 (March 2017): 327–35. https://doi.org/10.2217/pgs-2016-0175.Full Text Link to Item
-
Haga, Susanne B., Rachel Mills, Jivan Moaddeb, Nancy Allen LaPointe, Alex Cho, and Geoffrey S. Ginsburg. “Primary care providers' use of pharmacist support for delivery of pharmacogenetic testing.” Pharmacogenomics 18, no. 4 (March 2017): 359–67. https://doi.org/10.2217/pgs-2016-0177.Full Text Link to Item
-
Haga, Susanne B. “Integrating pharmacogenetic testing into primary care.” Expert Rev Precis Med Drug Dev 2, no. 6 (2017): 327–36. https://doi.org/10.1080/23808993.2017.1398046.Full Text Link to Item
-
Singh, Kavisha, Bruce Peyser, Gloria Trujillo, Nicholas Milazzo, Dillon Savard, Susanne B. Haga, Michael Musty, and Deepak Voora. “Rationale and design of the SLCO1B1 genotype guided statin therapy trial.” Pharmacogenomics 17, no. 17 (November 2016): 1873–80. https://doi.org/10.2217/pgs-2016-0065.Full Text Link to Item
-
Haga, Susanne B., Rachel Mills, Jivan Moaddeb, Nancy Allen Lapointe, Alex Cho, and Geoffrey S. Ginsburg. “Patient experiences with pharmacogenetic testing in a primary care setting.” Pharmacogenomics 17, no. 15 (October 2016): 1629–36. https://doi.org/10.2217/pgs-2016-0077.Full Text Link to Item
-
Haga, Susanne B., Rachel Mills, and Jivan Moaddeb. “Evaluation of a pharmacogenetic educational toolkit for community pharmacists.” Pharmacogenomics 17, no. 14 (September 2016): 1491–1502. https://doi.org/10.2217/pgs-2016-0002.Full Text Link to Item
-
Haga, Susanne B., and Rachel Mills. “A review of consent practices and perspectives for pharmacogenetic testing.” Pharmacogenomics 17, no. 14 (September 2016): 1595–1605. https://doi.org/10.2217/pgs-2016-0039.Full Text Link to Item
-
Haga, Susanne B. “Challenges of development and implementation of point of care pharmacogenetic testing.” Expert Rev Mol Diagn 16, no. 9 (September 2016): 949–60. https://doi.org/10.1080/14737159.2016.1211934.Full Text Link to Item
-
Haga, Susanne B., and Benjamin D. Solomon. “Considerations of pharmacogenetic testing in children.” Pharmacogenomics 17, no. 9 (June 2016): 975–77. https://doi.org/10.2217/pgs-2016-0073.Full Text Link to Item
-
Arora, Shubhangi, Eden Haverfield, Gabriele Richard, Susanne B. Haga, and Rachel Mills. “Clinical and Counseling Experiences of Early Adopters of Whole Exome Sequencing.” J Genet Couns 25, no. 2 (April 2016): 337–43. https://doi.org/10.1007/s10897-015-9876-y.Full Text Link to Item
-
Haga, Susanne B., and Jivan Moaddeb. “Proposal for a pharmacogenetics certificate program for pharmacists.” Pharmacogenomics 17, no. 6 (April 2016): 535–39. https://doi.org/10.2217/pgs.16.11.Full Text Link to Item
-
Haga, Susanne B., Jivan Moaddeb, Rachel Mills, Mahesh Patel, William Kraus, and Nancy M. Allen LaPointe. “Incorporation of pharmacogenetic testing into medication therapy management.” Pharmacogenomics 16, no. 17 (November 2015): 1931–41. https://doi.org/10.2217/pgs.15.124.Full Text Link to Item
-
Haga, Susanne B., Rachel Mills, Julia Aucoin, and Jeff Taekman. “Interprofessional education for personalized medicine through technology-based learning.” Per Med 12, no. 3 (June 2015): 237–43. https://doi.org/10.2217/pme.14.91.Full Text Link to Item
-
Haga, Susanne B., Nancy M. Allen LaPointe, and Jivan Moaddeb. “Challenges to integrating pharmacogenetic testing into medication therapy management.” J Manag Care Spec Pharm 21, no. 4 (April 2015): 346–52. https://doi.org/10.18553/jmcp.2015.21.4.346.Full Text Link to Item
-
Mills, Rachel, Jill Powell, William Barry, and Susanne B. Haga. “Information-seeking and sharing behavior following genomic testing for diabetes risk.” J Genet Couns 24, no. 1 (February 2015): 58–66. https://doi.org/10.1007/s10897-014-9736-1.Full Text Link to Item
-
Deverka, Patricia A., and Susanne B. Haga. “Comparative effectiveness research and demonstrating clinical utility for molecular diagnostic tests.” Clin Chem 61, no. 1 (January 2015): 142–44. https://doi.org/10.1373/clinchem.2014.223412.Full Text Link to Item
-
Gallagher, Patrick, Heather A. King, Susanne B. Haga, Lori A. Orlando, Scott V. Joy, Gloria M. Trujillo, William Michael Scott, et al. “Patient beliefs and behaviors about genomic risk for type 2 diabetes: implications for prevention.” J Health Commun 20, no. 6 (2015): 728–35. https://doi.org/10.1080/10810730.2015.1018563.Full Text Open Access Copy Link to Item
-
Haga, Susanne B., and Jivan Moaddeb. “Potential use of auxiliary labels to promote patient awareness of pharmacogenetic testing.” Pharmacogenomics 16, no. 4 (2015): 299–301. https://doi.org/10.2217/pgs.14.184.Full Text Link to Item
-
Haga, Susanne B., and Rachel Mills. “Nurses' communication of pharmacogenetic test results as part of discharge care.” Pharmacogenomics 16, no. 3 (2015): 251–56. https://doi.org/10.2217/pgs.14.173.Full Text Link to Item
-
Moaddeb, Jivan, Rachel Mills, and Susanne B. Haga. “Community pharmacists' experience with pharmacogenetic testing.” J Am Pharm Assoc (2003) 55, no. 6 (2015): 587–94. https://doi.org/10.1331/JAPhA.2015.15017.Full Text Link to Item
-
Haga, Susanne B., Nancy M. Allen LaPointe, Jivan Moaddeb, Rachel Mills, Mahesh Patel, and William E. Kraus. “Pilot study: incorporation of pharmacogenetic testing in medication therapy management services.” Pharmacogenomics 15, no. 14 (November 2014): 1729–37. https://doi.org/10.2217/pgs.14.118.Full Text Link to Item
-
Haga, Susanne B., Rachel Mills, and Hayden Bosworth. “Striking a balance in communicating pharmacogenetic test results: promoting comprehension and minimizing adverse psychological and behavioral response.” Patient Educ Couns 97, no. 1 (October 2014): 10–15. https://doi.org/10.1016/j.pec.2014.06.007.Full Text Link to Item
-
Haga, Susanne B., Nancy M Allen LaPointe, Alex Cho, Shelby D. Reed, Rachel Mills, Jivan Moaddeb, and Geoffrey S. Ginsburg. “Pilot study of pharmacist-assisted delivery of pharmacogenetic testing in a primary care setting.” Pharmacogenomics 15, no. 13 (September 2014): 1677–86. https://doi.org/10.2217/pgs.14.109.Full Text Link to Item
-
Mills, Rachel, and Susanne B. Haga. “Genomic counseling: next generation counseling.” J Genet Couns 23, no. 4 (August 2014): 689–92. https://doi.org/10.1007/s10897-013-9641-z.Full Text Link to Item
-
Mills, Rachel, William Barry, and Susanne B. Haga. “Public trust in genomic risk assessment for type 2 diabetes mellitus.” J Genet Couns 23, no. 3 (June 2014): 401–8. https://doi.org/10.1007/s10897-013-9674-3.Full Text Link to Item
-
Li, Josephine H., Scott V. Joy, Susanne B. Haga, Lori A. Orlando, William E. Kraus, Geoffrey S. Ginsburg, and Deepak Voora. “Genetically guided statin therapy on statin perceptions, adherence, and cholesterol lowering: a pilot implementation study in primary care patients.” J Pers Med 4, no. 2 (March 27, 2014): 147–62. https://doi.org/10.3390/jpm4020147.Full Text Link to Item
-
Haga, Susanne B., and Jivan Moaddeb. “Comparison of delivery strategies for pharmacogenetic testing services.” Pharmacogenet Genomics 24, no. 3 (March 2014): 139–45. https://doi.org/10.1097/FPC.0000000000000028.Full Text Link to Item
-
Zhao, Jennifer Q., and Susanne B. Haga. “Promoting the participant-researcher partnership.” Genet Med 16, no. 3 (March 2014): 228–30. https://doi.org/10.1038/gim.2013.118.Full Text Link to Item
-
Haga, S. B., W. T. Barry, R. Mills, L. Svetkey, S. Suchindran, H. F. Willard, and G. S. Ginsburg. “Impact of delivery models on understanding genomic risk for type 2 diabetes.” Public Health Genomics 17, no. 2 (2014): 95–104. https://doi.org/10.1159/000358413.Full Text Link to Item
-
Haga, Susanne B. “Delivering pharmacogenetic testing to the masses: an achievable goal?” Pharmacogenomics 15, no. 1 (January 2014): 1–4. https://doi.org/10.2217/pgs.13.211.Full Text Link to Item
-
Haga, Susanne B., Rachel Mills, Kathryn I. Pollak, Catherine Rehder, Adam H. Buchanan, Isaac M. Lipkus, Jennifer H. Crow, and Michael Datto. “Developing patient-friendly genetic and genomic test reports: formats to promote patient engagement and understanding.” Genome Med 6, no. 7 (2014): 58. https://doi.org/10.1186/s13073-014-0058-6.Full Text Link to Item
-
Haga, Susanne B., Rachel Mills, and Jivan Moaddeb. “Pharmacogenetic information for patients on drug labels.” Pharmgenomics Pers Med 7 (2014): 297–305. https://doi.org/10.2147/PGPM.S67876.Full Text Link to Item
-
Haga, S. B., and N. M. A. LaPointe. “The potential impact of pharmacogenetic testing on medication adherence.” Pharmacogenomics J 13, no. 6 (December 2013): 481–83. https://doi.org/10.1038/tpj.2013.33.Full Text Link to Item
-
Haga, Susanne B. “100k Genome Project: sequencing and much more.” Per Med 10, no. 8 (November 2013): 761–64. https://doi.org/10.2217/pme.13.80.Full Text Link to Item
-
Clayton, Ellen Wright, Susanne Haga, Patricia Kuszler, Emily Bane, Krysta Shutske, and Wylie Burke. “Managing incidental genomic findings: legal obligations of clinicians.” Genet Med 15, no. 8 (August 2013): 624–29. https://doi.org/10.1038/gim.2013.7.Full Text Link to Item
-
Moaddeb, Jivan, and Susanne B. Haga. “Pharmacogenetic testing: Current Evidence of Clinical Utility.” Ther Adv Drug Saf 4, no. 4 (August 1, 2013): 155–69. https://doi.org/10.1177/2042098613485595.Full Text Link to Item
-
Haga, Susanne B., Katie D. Rosanbalm, Larry Boles, Genevieve M. Tindall, Troy M. Livingston, and Julianne M. O’Daniel. “Promoting public awareness and engagement in genome sciences.” J Genet Couns 22, no. 4 (August 2013): 508–16. https://doi.org/10.1007/s10897-013-9577-3.Full Text Link to Item
-
Haga, Susanne B., Wylie Burke, and Robert Agans. “Primary-care physicians' access to genetic specialists: an impediment to the routine use of genomic medicine?” Genet Med 15, no. 7 (July 2013): 513–14. https://doi.org/10.1038/gim.2012.168.Full Text Link to Item
-
Mills, Rachel, and Susanne B. Haga. “Clinical delivery of pharmacogenetic testing services: a proposed partnership between genetic counselors and pharmacists.” Pharmacogenomics 14, no. 8 (June 2013): 957–68. https://doi.org/10.2217/pgs.13.76.Full Text Link to Item
-
Haga, Susanne B., William T. Barry, Rachel Mills, Geoffrey S. Ginsburg, Laura Svetkey, Jennifer Sullivan, and Huntington F. Willard. “Public knowledge of and attitudes toward genetics and genetic testing.” Genet Test Mol Biomarkers 17, no. 4 (April 2013): 327–35. https://doi.org/10.1089/gtmb.2012.0350.Full Text Link to Item
-
Haga, S. B., W. Burke, G. S. Ginsburg, R. Mills, and R. Agans. “Primary care physicians' knowledge of and experience with pharmacogenetic testing.” Obstetrical and Gynecological Survey 68, no. 2 (February 1, 2013): 91–93. https://doi.org/10.1097/01.ogx.0000427617.89027.ca.Full Text
-
Mills, Rachel, Deepak Voora, Bruce Peyser, and Susanne B. Haga. “Delivering pharmacogenetic testing in a primary care setting.” Pharmgenomics Pers Med 6 (2013): 105–12. https://doi.org/10.2147/PGPM.S50598.Full Text Link to Item
-
Haga, Susanne B., and Jennifer Q. Zhao. “Stakeholder views on returning research results.” Adv Genet 84 (2013): 41–81. https://doi.org/10.1016/B978-0-12-407703-4.00002-5.Full Text Link to Item
-
Hresko, Andrew, and Susanne B. Haga. “Insurance coverage policies for personalized medicine.” J Pers Med 2, no. 4 (October 30, 2012): 201–16. https://doi.org/10.3390/jpm2040201.Full Text Link to Item
-
Haga, S. B., W. Burke, G. S. Ginsburg, R. Mills, and R. Agans. “Primary care physicians' knowledge of and experience with pharmacogenetic testing.” Clin Genet 82, no. 4 (October 2012): 388–94. https://doi.org/10.1111/j.1399-0004.2012.01908.x.Full Text Link to Item
-
Haga, S. B., J. M. O’Daniel, G. M. Tindall, R. Mills, I. Lipkus, and R. Agans. “Response to Newman et al.” Clinical Genetics 82, no. 2 (August 1, 2012): 203. https://doi.org/10.1111/j.1399-0004.2012.01874.x.Full Text
-
Haga, S. B., J. M. O’Daniel, G. M. Tindall, R. Mills, I. M. Lipkus, and R. Agans. “Survey of genetic counselors and clinical geneticists' use and attitudes toward pharmacogenetic testing.” Clin Genet 82, no. 2 (August 2012): 115–20. https://doi.org/10.1111/j.1399-0004.2012.01848.x.Full Text Link to Item
-
Mills, Rachel A., Susanne B. Haga, and Geoffrey S. Ginsburg. “Genetic testing: clinical and personal utility.” Virtual Mentor 14, no. 8 (August 1, 2012): 604–9. https://doi.org/10.1001/virtualmentor.2012.14.8.ecas1-1208.Full Text Link to Item
-
Kraus, William E., Susanne B. Haga, Howard L. McLeod, Judd Staples, and Geoffrey S. Ginsburg. “Conference Scene: Is personalized medicine ready for prime time?” Per Med 9, no. 5 (July 2012): 475–78. https://doi.org/10.2217/pme.12.57.Full Text Link to Item
-
Haga, S. B., J. M. O’Daniel, G. M. Tindall, I. R. Lipkus, and R. Agans. “Survey of US public attitudes toward pharmacogenetic testing.” Pharmacogenomics J 12, no. 3 (June 2012): 197–204. https://doi.org/10.1038/tpj.2011.1.Full Text Link to Item
-
Haga, Susanne B., Genevieve Tindall, and Julianne M. O’Daniel. “Public perspectives about pharmacogenetic testing and managing ancillary findings.” Genet Test Mol Biomarkers 16, no. 3 (March 2012): 193–97. https://doi.org/10.1089/gtmb.2011.0118.Full Text Link to Item
-
O’Daniel, Julianne M., Katie D. Rosanbalm, Larry Boles, Genevieve M. Tindall, Troy M. Livingston, and Susanne B. Haga. “Enhancing geneticists' perspectives of the public through community engagement.” Genet Med 14, no. 2 (February 2012): 243–49. https://doi.org/10.1038/gim.2011.29.Full Text Link to Item
-
Cho, Alex H., Ley A. Killeya-Jones, Julianne M. O’Daniel, Kensaku Kawamoto, Patrick Gallagher, Susanne Haga, Joseph E. Lucas, Gloria M. Trujillo, Scott V. Joy, and Geoffrey S. Ginsburg. “Effect of genetic testing for risk of type 2 diabetes mellitus on health behaviors and outcomes: study rationale, development and design.” Bmc Health Serv Res 12 (January 18, 2012): 16. https://doi.org/10.1186/1472-6963-12-16.Full Text Open Access Copy Link to Item
-
Haga, Susanne B., Genevieve Tindall, and Julianne M. O’Daniel. “Professional perspectives about pharmacogenetic testing and managing ancillary findings.” Genet Test Mol Biomarkers 16, no. 1 (January 2012): 21–24. https://doi.org/10.1089/gtmb.2011.0045.Full Text Link to Item
-
Kanakamedala, Priyanka, and Susanne B. Haga. “Characterization of clinical study populations by race and ethnicity in biomedical literature.” Ethn Dis 22, no. 1 (2012): 96–101.Link to Item
-
Haga, Susanne B., Kensaku Kawamoto, Robert Agans, and Geoffrey S. Ginsburg. “Consideration of patient preferences and challenges in storage and access of pharmacogenetic test results.” Genet Med 13, no. 10 (October 2011): 887–90. https://doi.org/10.1097/GIM.0b013e31822077a5.Full Text Link to Item
-
Haga, Susanne B., Julianne M. O’Daniel, Genevieve M. Tindall, Isaac R. Lipkus, and Robert Agans. “Public attitudes toward ancillary information revealed by pharmacogenetic testing under limited information conditions.” Genet Med 13, no. 8 (August 2011): 723–28. https://doi.org/10.1097/GIM.0b013e31821afcc0.Full Text Link to Item
-
Haga, Susanne B., Madeline M. Carrig, Julianne M. O’Daniel, Lori A. Orlando, Ley A. Killeya-Jones, Geoffrey S. Ginsburg, and Alex Cho. “Genomic risk profiling: attitudes and use in personal and clinical care of primary care physicians who offer risk profiling.” J Gen Intern Med 26, no. 8 (August 2011): 834–40. https://doi.org/10.1007/s11606-011-1651-7.Full Text Link to Item
-
Haga, S. B., and W. Burke. “Practical ethics: establishing a pathway to benefit for complex pharmacogenomic tests.” Clin Pharmacol Ther 90, no. 1 (July 2011): 25–27. https://doi.org/10.1038/clpt.2011.71.Full Text Link to Item
-
Haga, S. B., and J. O’Daniel. “Public perspectives regarding data-sharing practices in genomics research.” Public Health Genomics 14, no. 6 (2011): 319–24. https://doi.org/10.1159/000324705.Full Text Link to Item
-
O’Daniel, J., and S. B. Haga. “Public perspectives on returning genetics and genomics research results.” Public Health Genomics 14, no. 6 (2011): 346–55. https://doi.org/10.1159/000324933.Full Text Link to Item
-
Heaney, Christopher, Genevieve Tindall, Joe Lucas, and Susanne B. Haga. “Researcher practices on returning genetic research results.” Genet Test Mol Biomarkers 14, no. 6 (December 2010): 821–27. https://doi.org/10.1089/gtmb.2010.0066.Full Text Open Access Copy Link to Item
-
Surh, Linda C., Michael A. Pacanowski, Susanne B. Haga, Stuart Hobbs, Lawrence J. Lesko, Scott Gottlieb, Marisa Papaluca-Amati, et al. “Learning from product labels and label changes: how to build pharmacogenomics into drug-development programs.” Pharmacogenomics 11, no. 12 (December 2010): 1637–47. https://doi.org/10.2217/pgs.10.138.Full Text Link to Item
-
Haga, Susanne B. “Analysis of educational materials and destruction/opt-out initiatives for storage and use of residual newborn screening samples.” Genet Test Mol Biomarkers 14, no. 5 (October 2010): 587–92. https://doi.org/10.1089/gtmb.2010.0010.Full Text Open Access Copy Link to Item
-
O’Daniel, Julianne M., Susanne B. Haga, and Huntington F. Willard. “Considerations for the impact of personal genome information: a study of genomic profiling among genetics and genomics professionals.” J Genet Couns 19, no. 4 (August 2010): 387–401. https://doi.org/10.1007/s10897-010-9297-x.Full Text Link to Item
-
Haga, Susanne B. “Impact of limited population diversity of genome-wide association studies.” Genet Med 12, no. 2 (February 2010): 81–84. https://doi.org/10.1097/GIM.0b013e3181ca2bbf.Full Text Link to Item
-
O’Daniel, J., J. Lucas, P. Deverka, D. Ermentrout, G. Silvey, D. F. Lobach, and S. B. Haga. “Factors influencing uptake of pharmacogenetic testing in a diverse patient population.” Public Health Genomics 13, no. 1 (2010): 48–54. https://doi.org/10.1159/000217795.Full Text Link to Item
-
Haga, Susanne B., and Sharon F. Terry. “Ensuring the safe use of genomic medicine in children.” Clin Pediatr (Phila) 48, no. 7 (September 2009): 703–8. https://doi.org/10.1177/0009922809335736.Full Text Link to Item
-
Haga, Susanne B. “Ethical issues of predictive genetic testing for diabetes.” J Diabetes Sci Technol 3, no. 4 (July 1, 2009): 781–88. https://doi.org/10.1177/193229680900300427.Full Text Link to Item
-
Haga, S. B., L. R. Warner, and J. O’Daniel. “The potential of a placebo/nocebo effect in pharmacogenetics.” Public Health Genomics 12, no. 3 (2009): 158–62. https://doi.org/10.1159/000189628.Full Text Link to Item
-
Haga, Susanne B., and Wylie Burke. “Pharmacogenetic testing: not as simple as it seems.” Genet Med 10, no. 6 (June 2008): 391–95. https://doi.org/10.1097/GIM.0b013e31817701d4.Full Text Link to Item
-
Haga, Susanne B., and Huntington F. Willard. “Letting the genome out of the bottle.” N Engl J Med 358, no. 20 (May 15, 2008): 2184. https://doi.org/10.1056/NEJMc086053.Full Text Link to Item
-
Haga, Susanne B., and Laura M. Beskow. “Ethical, legal, and social implications of biobanks for genetics research.” Adv Genet 60 (2008): 505–44. https://doi.org/10.1016/S0065-2660(07)00418-X.Full Text Link to Item
-
Silvey, Garry M., Susanne B. Haga, Julianne M. O’Daniel, Patricia Deverka, Dania M. Ermentrout, Kevin J. Anstrom, and David F. Lobach. “Determining user preferences between touch and pen data entry methods in the Tablet PC computing environment.” Amia Annu Symp Proc, October 11, 2007, 1115.Link to Item
-
Haga, Susanne B., Kenneth E. Thummel, and Wylie Burke. “Adding pharmacogenetics information to drug labels: lessons learned.” Pharmacogenet Genomics 16, no. 12 (December 2006): 847–54. https://doi.org/10.1097/01.fpc.0000236322.88433.ac.Full Text Link to Item
-
Haga, Susanne B., and Huntington F. Willard. “Defining the spectrum of genome policy.” Nat Rev Genet 7, no. 12 (December 2006): 966–72. https://doi.org/10.1038/nrg2003.Full Text Link to Item
-
Haga, Susanne B. “Genomics-based labeling and attribution: a case for integrating social sciences into personalized medicine research.” Per Med 3, no. 3 (August 2006): 317–23. https://doi.org/10.2217/17410541.3.3.317.Full Text Link to Item
-
Haga, Susanne B., and Geoffrey S. Ginsburg. “Prescribing BiDil: is it black and white?” J Am Coll Cardiol 48, no. 1 (July 4, 2006): 12–14. https://doi.org/10.1016/j.jacc.2006.04.017.Full Text Link to Item
-
Ginsburg, Geoffrey S., and Susanne B. Haga. “Translating genomic biomarkers into clinically useful diagnostics.” Expert Rev Mol Diagn 6, no. 2 (March 2006): 179–91. https://doi.org/10.1586/14737159.6.2.179.Full Text Link to Item
-
Haga, Susanne B. “Teaching resources for genetics.” Nat Rev Genet 7, no. 3 (March 2006): 223–29. https://doi.org/10.1038/nrg1803.Full Text Link to Item
-
Rich, E. C., W. Burke, C. J. Heaton, S. Haga, L. Pinsky, M. P. Short, and L. Acheson. “Erratum: Reconsidering the family history in primary care (Journal of General Internal Medicine (2004) 19 (273-280)).” Journal of General Internal Medicine 20, no. 3 (March 1, 2005): 315. https://doi.org/10.1111/j.1525-1497.2005.00bmi.x.Full Text
-
Haga, S. B. “Embracing our duty.” American Journal of Human Genetics 76, no. 4 (January 1, 2005): 547. https://doi.org/10.1086/429097.Full Text
-
Haga, Susanne B., and Wylie Burke. “Using pharmacogenetics to improve drug safety and efficacy.” Jama 291, no. 23 (June 16, 2004): 2869–71. https://doi.org/10.1001/jama.291.23.2869.Full Text Link to Item
-
Rich, Eugene C., Wylie Burke, Caryl J. Heaton, Susanne Haga, Linda Pinsky, M Priscilla Short, and Louise Acheson. “Reconsidering the family history in primary care.” J Gen Intern Med 19, no. 3 (March 2004): 273–80. https://doi.org/10.1111/j.1525-1497.2004.30401.x.Full Text Link to Item
-
Haga, Susanne B., Muin J. Khoury, and Wylie Burke. “Genomic profiling to promote a healthy lifestyle: not ready for prime time.” Nat Genet 34, no. 4 (August 2003): 347–50. https://doi.org/10.1038/ng0803-347.Full Text Link to Item
-
Haga, Susanne B., and J Craig Venter. “Genetics. FDA races in wrong direction.” Science 301, no. 5632 (July 25, 2003): 466. https://doi.org/10.1126/science.1087004.Full Text Link to Item
-
Haga, Susanne B., and Joann A. Boughman. “The genetics workforce and workload.” Genet Med 5, no. 1 (2003): 55–57. https://doi.org/10.1097/00125817-200301000-00009.Full Text Link to Item
-
Chase, Michael B., Sidong Fu, Susanne B. Haga, Gregory Davenport, Holly Stevenson, Khanh Do, Doris Morgan, Alex L. Mah, and Patricia E. Berg. “BP1, a homeodomain-containing isoform of DLX4, represses the beta-globin gene.” Mol Cell Biol 22, no. 8 (April 2002): 2505–14. https://doi.org/10.1128/MCB.22.8.2505-2514.2002.Full Text Link to Item
-
Fu, S., H. Stevenson, J. W. Strovel, S. B. Haga, J. Stamberg, K. Do, and P. E. Berg. “Distinct functions of two isoforms of a homeobox gene, BP1 and DLX7, in the regulation of the beta-globin gene.” Gene 278, no. 1–2 (October 31, 2001): 131–39. https://doi.org/10.1016/s0378-1119(01)00716-8.Full Text Link to Item
-
Haga, S. B., S. Fu, J. E. Karp, D. D. Ross, D. M. Williams, W. D. Hankins, F. Behm, et al. “BP1, a new homeobox gene, is frequently expressed in acute leukemias.” Leukemia 14, no. 11 (November 2000): 1867–75. https://doi.org/10.1038/sj.leu.2401912.Full Text Link to Item
-
Chase, M. B., S. B. Haga, W. D. Hankins, D. M. Williams, Z. Bi, J. W. Strovel, C. Obriecht, and P. E. Berg. “Binding of HMG-I(Y) elicits structural changes in a silencer of the human beta-globin gene.” Am J Hematol 60, no. 1 (January 1999): 27–35. https://doi.org/10.1002/(sici)1096-8652(199901)60:1<27::aid-ajh6>3.0.co;2-0.Full Text Link to Item
-
-
Book Sections
-
Haga, S. B. “Precision medicine: Overview and challenges to clinical implementation.” In Principles of Gender-Specific Medicine: Sex and Gender-Specific Biology in the Postgenomic Era, 513–29, 2023. https://doi.org/10.1016/B978-0-323-88534-8.00020-1.Full Text
-
Ginsburg, G. S., and S. B. Haga. “Foundations and application of precision medicine.” In Emery and Rimoin’s Principles and Practice of Medical Genetics and Genomics: Foundations, 21–45, 2018. https://doi.org/10.1016/B978-0-12-812537-3.00002-0.Full Text
-
Haga, S. B. “Precision Medicine and Challenges in Research and Clinical Implementation.” In Principles of Gender-Specific Medicine: Gender in the Genomic Era: Third Edition, 717–32, 2017. https://doi.org/10.1016/B978-0-12-803506-1.00021-8.Full Text
-
Haga, S. B. “Overview of Policy, Ethical, and Social Considerations in Genomic and Personalized Medicine.” In Genomic and Precision Medicine: Primary Care: Third Edition, 19–43, 2017. https://doi.org/10.1016/B978-0-12-800685-6.00005-9.Full Text
-
Haga, S. B. “Overview of Policy, Ethical and Social Considerations in Genomic and Personalized Medicine.” In Genomic and Personalized Medicine, 1:392–404, 2013. https://doi.org/10.1016/B978-0-12-382227-7.00034-3.Full Text
-
Haga, S. B. “Overview of Policy, Ethical and Social Considerations in Genomic and Personalized Medicine.” In Genomic and Personalized Medicine, 392–404, 2012. https://doi.org/10.1016/B978-0-12-382227-7.00034-3.Full Text
-
Haga, S. B. “Genome Policy Considerations for Genomic Medicine.” In Essentials of Genomic and Personalized Medicine, 209–22, 2010. https://doi.org/10.1016/B978-0-12-374934-5.00018-0.Full Text
-
Haga, S. B. “From Sequence to Genomic Medicine: Genome Policy Considerations.” In Genomic and Personalized Medicine, Two-Vol Set, 387–400, 2009. https://doi.org/10.1016/B978-0-12-369420-1.00033-0.Full Text
-
Haga, Susanne B. “From Sequence to Genomic Medicine: Genome Policy Considerations.” In GENOMIC AND PERSONALIZED MEDICINE, VOL 1, 388–400, 2009.Link to Item
-
Haga, S. B. “From Sequence to Genomic Medicine: Genome Policy Considerations.” In Genomic and Personalized Medicine: V1-2, 387–400, 2008. https://doi.org/10.1016/B978-0-12-369420-1.00033-0.Full Text
-
-
Conference Papers
-
Cho, Alex, Allison Vorderstrasse, Sunil Suchindran, Joseph Lucas, William Michael Scott, Marylou Bembe, Dana Baker, et al. “T2D Genetic Risk Counseling & Testing in Primary Care.” In Diabetes, 62:A196–A196. AMER DIABETES ASSOC, 2013.Link to Item
-
-
- Teaching & Mentoring
-
Recent Courses
- BIOLOGY 325: Current Technologies in Genomics and Precision Medicine 2023
- BIOLOGY 391: Independent Study: Advanced Topics 2023
- BIOLOGY 491: Independent Study: Advanced Topics 2023
- FOCUS 195FS: Special Topics in Focus 2023
- MGM 120FS: Ethical Implications of Genetic and Genomic Research 2023
- MGM 325: Current Technologies in Genomics and Precision Medicine 2023
- MGM 370: Pharmacogenomics and Personalized Medicine 2023
- PHARM 370: Pharmacogenomics and Personalized Medicine 2023
- PUBPOL 186FS: Ethical Implications of Genetic and Genomic Research 2023
- BIOLOGY 325: Current Technologies in Genomics and Precision Medicine 2022
- FOCUS 195FS: Special Topics in Focus 2022
- GLHLTH 393: Research Independent Study in Global Health 2022
- MGM 120FS: Ethical Implications of Genetic and Genomic Research 2022
- MGM 325: Current Technologies in Genomics and Precision Medicine 2022
- MGM 370: Pharmacogenomics and Personalized Medicine 2022
- PHARM 370: Pharmacogenomics and Personalized Medicine 2022
- PUBPOL 186FS: Ethical Implications of Genetic and Genomic Research 2022
- BIOLOGY 325: Current Technologies in Genomics and Precision Medicine 2021
- ISS 493: ISS Research Independent Study 2021
- ISS 795: Bass Connections Information, Society & Culture Research Team 2021
- MGM 120FS: Ethical Implications of Genetic and Genomic Research 2021
- MGM 325: Current Technologies in Genomics and Precision Medicine 2021
- MGM 370: Pharmacogenomics and Personalized Medicine 2021
- PHARM 370: Pharmacogenomics and Personalized Medicine 2021
- PUBPOL 186FS: Ethical Implications of Genetic and Genomic Research 2021
- Scholarly, Clinical, & Service Activities
-
Outreach & Engaged Scholarship
- Bass Connections Team Leader. Enabling Precision Health and Medicine. 2020 - 2021 2020 - 2021
- Bass Connections Team Leader. Enabling Precision Health and Medicine. 2019 - 2020 2019 - 2020
- Bass Connections Faculty Team Leader. Enabling Precision Health and Medicine. 2018 - 2019 2018 - 2019
- Bass Connections Faculty Team Member . Blue Devil Resistome Project. August 2017 - May 2018 2017 - 2018
- Bass Connections Faculty Team Member. Enabling Precision Health and Medicine. August 2017 - May 2018 2017 - 2018
Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.